Adjuvante Behandlung des caninen Hämangiosarkoms der Milz mit der autologen dendritischen Zelltherapie – eine prospektive, placebokontrollierte, randomisierte Doppelblindstudie

Overview of attention for article published in Tierärztliche Praxis (Klein- und Heimtiere), December 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,558 followers.

Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy – a prospective, randomized double-blind study. https://t.co/9vwdNcm47q

15 Dec 2023

Reply Repost Favourite

Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy – a prospective, randomized double-blind study. https://t.co/exXQEBVOV5

07 Dec 2023

Reply Repost Favourite

Adjuvant treatment of canine splenic #hemangiosarcoma with autologous dendritic cell therapy. Immunotherapy using autologous, immature and unprimed dendritic cells failed to show efficacy on tumor-free interval and survival time https://t.co/yj4K2UkIG4

07 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.